Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03592745 · ClinicalTrials.gov registry record · Phase 2
Transcutaneous Vagus Nerve Stimulation (tVNS) and Robotic Training to Improve Arm Function After Stroke
A Phase 2 study, sponsored by Northwell Health.
- Completed
- Registry status
- Phase 2
- Development phase
- 36
- Enrollment target
NCT03592745 is a Phase 2 study that has completed, run by Northwell Health. The registered enrollment target is 36 participants.
The verdict
NCT03592745, a Phase 2 study, has completed, sponsored by Northwell Health.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to evaluate if multiple therapy sessions of Transcutaneous Vagus Nerve Stimulation (tVNS) combined with robotic arm therapy lead to a greater functional recovery in upper limb mobility after stroke than that provided by robotic arm therapy in a sham stimulation condition.
Interventions
- DEVICE Transcutaneous Vagus Nerve Stimulation (tVNS)
- DEVICE Sham Transcutaneous Vagus Nerve Stimulation (tVNS)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2018-08-09 |
| Est. Completion | 2021-06-01 |
| Phase | Phase 2 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03592745
The ClinicalTrials.gov registry entry for NCT03592745 describes a study currently listed as completed, categorized as Phase 2. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Northwell Health, which has 370 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Transcutaneous Vagus Nerve Stimulation (tVNS) is the first listed.
NCT03592745 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03592745 about?
NCT03592745 is a clinical study titled "Transcutaneous Vagus Nerve Stimulation (tVNS) and Robotic Training to Improve Arm Function After Stroke". The purpose of this study is to evaluate if multiple therapy sessions of Transcutaneous Vagus Nerve Stimulation (tVNS) combined with robotic arm therapy lead to a greater functional recovery in upper limb mobility after stroke than that provided by robotic arm therapy in a sham stimulation condition...
What is the current status of trial NCT03592745?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 36 participants. The study started on 2018-08-09. Estimated completion is 2021-06-01.
What interventions are being tested in trial NCT03592745?
The interventions under investigation include: Transcutaneous Vagus Nerve Stimulation (tVNS) (DEVICE), Sham Transcutaneous Vagus Nerve Stimulation (tVNS) (DEVICE).
Who is sponsoring clinical trial NCT03592745?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.